Progyny up 6% on insider buys
投稿者Ainvest
2024年12月27日 金曜日 午前 8:44 Et1分で読める
PGNY--
One of the most significant purchases was made by Ali Motamed, the Chief Investment Officer of Invenomic Capital Management. Motamed acquired 1,760,706 shares of PGNY, worth approximately $29.5 million [2]. This transaction represented a sizable 1.62% increase in Motamed's total holdings of the company [2].
Another notable insider purchase was made by Philip Timon, the Founder and Chief Investment Officer of Owls Nest Partners. Timon sold 1,523,147 shares of PGNY but simultaneously purchased 1,523,147 new shares [2]. Although this transaction resulted in no net change to Timon's overall holdings, it demonstrated his confidence in the company's future prospects.
The hedge fund with the largest stake in PGNY is Farallon Capital, managed by Thomas Steyer. Steyer reduced his holdings by selling 931,307 shares of the company, worth around $15.6 million [2]. Despite this sale, Steyer still holds a significant 0.07% stake in PGNY [2].
Steve Cohen, the Founder and Chief Executive Officer of Point72 Asset Management, also made a notable purchase of 789,418 shares of PGNY, worth approximately $13.2 million [2]. This transaction represented a substantial 228% increase in Cohen's total holdings of the company [2].
Israel Englander, the Founder and Chief Investment Officer of Millennium Management, acquired 563,535 shares of PGNY, worth around $9.4 million [2]. This purchase represented a 6% increase in Englander's overall holdings of the company [2].
The insider buying activity at PGNY is a positive sign for the company, as it demonstrates confidence from key executives and prominent investors. With a strong focus on fertility benefits, PGNY is well-positioned to capitalize on the growing demand for healthcare services in this area [1].
References:
[1] OpenInsider. Progyny Inc. Retrieved November 15, 2024, from http://openinsider.com/PGNY
[2] Insidermonkey. Progyny Inc. Hedge Fund Trading. Retrieved November 15, 2024, from https://www.insidermonkey.com/insider-trading/company/progyny+inc/1551306/
Progyny up 6% on insider buys
Progyny Inc. (PGNY), a healthcare services company specializing in fertility benefits, experienced a notable surge of 6% in its stock price on November 14, 2024 [1]. This uptick can be attributed to a series of insider purchases made by key executives and prominent hedge funds [2].One of the most significant purchases was made by Ali Motamed, the Chief Investment Officer of Invenomic Capital Management. Motamed acquired 1,760,706 shares of PGNY, worth approximately $29.5 million [2]. This transaction represented a sizable 1.62% increase in Motamed's total holdings of the company [2].
Another notable insider purchase was made by Philip Timon, the Founder and Chief Investment Officer of Owls Nest Partners. Timon sold 1,523,147 shares of PGNY but simultaneously purchased 1,523,147 new shares [2]. Although this transaction resulted in no net change to Timon's overall holdings, it demonstrated his confidence in the company's future prospects.
The hedge fund with the largest stake in PGNY is Farallon Capital, managed by Thomas Steyer. Steyer reduced his holdings by selling 931,307 shares of the company, worth around $15.6 million [2]. Despite this sale, Steyer still holds a significant 0.07% stake in PGNY [2].
Steve Cohen, the Founder and Chief Executive Officer of Point72 Asset Management, also made a notable purchase of 789,418 shares of PGNY, worth approximately $13.2 million [2]. This transaction represented a substantial 228% increase in Cohen's total holdings of the company [2].
Israel Englander, the Founder and Chief Investment Officer of Millennium Management, acquired 563,535 shares of PGNY, worth around $9.4 million [2]. This purchase represented a 6% increase in Englander's overall holdings of the company [2].
The insider buying activity at PGNY is a positive sign for the company, as it demonstrates confidence from key executives and prominent investors. With a strong focus on fertility benefits, PGNY is well-positioned to capitalize on the growing demand for healthcare services in this area [1].
References:
[1] OpenInsider. Progyny Inc. Retrieved November 15, 2024, from http://openinsider.com/PGNY
[2] Insidermonkey. Progyny Inc. Hedge Fund Trading. Retrieved November 15, 2024, from https://www.insidermonkey.com/insider-trading/company/progyny+inc/1551306/

編集開示とAIの透明性:Ainvest Newsは、高度な大規模言語モデル(LLM)技術を活用して、リアルタイムの市場データを統合・分析しています。最高水準の信頼性を確保するため、すべての記事は厳格な「Human-in-the-loop(人による検証)」プロセスを経ています。
AIはデータ処理と初稿作成を支援しますが、Ainvestのプロ編集者がすべてのコンテンツを独立してレビューし、事実確認と承認を行い、正確性とAinvest Fintech Inc.の編集基準への準拠を担保します。この人的監督は、AIのハルシネーションを抑制し、金融文脈の妥当性を確保するために設けられています。
投資に関する注意:本コンテンツは情報提供のみを目的としており、専門的な投資・法律・財務アドバイスを構成するものではありません。市場には固有のリスクがあります。意思決定の前に、独自の調査を行うか、資格を有するファイナンシャルアドバイザーに相談することを推奨します。Ainvest Fintech Inc.は、本情報に基づいて行われた行為について一切の責任を負いません。誤りを見つけましたか?問題を報告



コメント
まだコメントはありません